nib offers cover for non-PHARMAC medicines
The new add-on cover, non-PHARMAC Plus, is available from today through nib’s adviser and group distribution channels with members able to add to their new or existing hospital cover.
PHARMAC is the government agency responsible for deciding which medicines are subsidised as part of New Zealand's public health system.
Some potentially life-saving drugs are not subsidised by PHARMAC, such as the melanoma drug Tafinlar.
Benefit limits range from $20,000 to $300,000 per member per year, allowing members to choose the level of cover that best suits their health needs and budget.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.